Dalbavancin is a novel antimicrobial against Gram-positive pathogens: clinical experience beyond labeled indications
FI: 0,892
Type: Article
Collaboration
Year: 2020
Writers
Nunez-Nunez, M; Casas-Hidalgo, I; Garcia-Fumero, R; Vallejo-Rodriguez, I; Anguita-Santos, F; Hernandez-Quero, J; Head-Barrera, J; Ruiz-Sancho, A
Magazine
Title: EUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE
Quartile
- Q4